Long term anti-vascular endothelial growth factor receptor treatment impairs renal function in renal cell carcinoma

被引：0
|
作者：
Naito, S. [1 ]
Otake, K. [1 ]
Tsuchiya, N. [1 ]
机构：
[1] Yamagata Univ, Fac Med, Dept Urol, Yamagata, Japan
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0334
引用
收藏
页码：S486 / S486
页数：1
相关论文
共 50 条
  • [41] Intravitreal Anti-Vascular Endothelial Growth Factor Treatment and the Risk of Thromboembolism
    Schlenker, Matthew B.
    Thiruchelvam, Deva
    Redelmeier, Donald A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (03) : 569 - 580
  • [42] Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions
    Browning, David J.
    CURRENT DRUG THERAPY, 2012, 7 (02) : 101 - 116
  • [43] Intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
    Cho, Han Joo
    Cho, Soo Yeon
    Jung, Seong Heon
    Kim, Chul Gu
    Lee, Dong Won
    Kim, Jong Woo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [44] Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels
    Sitohy, Basel
    Chang, Sunghee
    Sciuto, Tracey E.
    Masse, Elizabeth
    Shen, Mei
    Kang, Peter M.
    Jaminet, Shou-Ching
    Benjamin, Laura E.
    Bhatt, Rupal S.
    Dvorak, Ann M.
    Nagy, Janice A.
    Dvorak, Harold F.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (10): : 2337 - 2347
  • [45] Beware renal adverse effects of anti-vascular endothelial growth factor treatment (vol 344, e3838, 2012)
    Keir, L.
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [46] Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia
    Franco, M
    Man, S
    Chen, L
    Emmenegger, U
    Shaked, Y
    Cheung, AM
    Brown, AS
    Hicklin, DJ
    Foster, FS
    Kerbel, RS
    CANCER RESEARCH, 2006, 66 (07) : 3639 - 3648
  • [47] Long-Term Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy
    Chang, Young Suk
    Kim, Jae Hui
    Kim, Kyung Min
    Kim, Jong Woo
    Lee, Tae Gon
    Kim, Chul Gu
    Cho, Sung Won
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (04) : 219 - 224
  • [48] The Role of Anti-Epidermal Growth Factor Receptor and Anti-Vascular Endothelial Growth Factor Therapies in the Treatment of Non-Small-Cell Lung Cancer
    Langer, Corey
    Soria, Jean-Charles
    CLINICAL LUNG CANCER, 2010, 11 (02) : 82 - 90
  • [49] Vascular endothelial growth factor in relation to nuclear factor Kappa B in renal cell carcinoma
    Dordevic, Gordana
    Matusan, Koviljka
    Sinozic, Emina
    Licul, Vanja
    Grahovac, Blazenka
    Jonjic, Nives
    VIRCHOWS ARCHIV, 2007, 451 (02) : 520 - 520
  • [50] Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
    Franczyk, Beata
    Rysz, Jacek
    Lawinski, Janusz
    Cialkowska-Rysz, Aleksandra
    Gluba-Brzozka, Anna
    BIOMEDICINES, 2023, 11 (01)
12345